Download 2015 round of grants - Leukaemia Foundation

 VisiontoCure
The Leukaemia Foundation has invested $38 million in blood cancer
research since 2005. The 2015 round of new research grants, worth
$3.9 million, are listed below. This takes the total number of projects
currently being funded, to 49. POST DOCTORAL FELLOWSHIPS PHD SCHOLARSHIPS Dr S. Grabow Walter and Eliza Hall Institute of Medical Research, VIC Harnessing the cell death cycle to develop novel therapies for leukaemia and lymphoma $200,000 / 2015 to 2016 Ms M. Brennan Walter and Eliza Hall Institute of Medical Research, VIC Testing a new anti‐cancer drug for the treatment of lymphoma $120,000 / 2015 to 2017 Dr O. Gilan Peter MacCallum Cancer Centre, VIC Supported by ‘Shooting Star’ Kate Leith Combination of drugs that regulate the packaging of DNA to treat leukaemia
$300,000 / 2015 to 2017 Mr D. Tyler The University of Melbourne, Peter MacCallum Cancer Centre, VIC Visualising the mechanism of action of cancer therapies $120,000 / 2015 to 2017 Dr A. Newbold Miss R. Delconte Walter and Eliza Hall Institute of Medical Research, VIC The University of Melbourne, Peter MacCallum Cancer Centre, VIC Supported by ‘Shooting Star’ Kristine Lawn Supported by ‘Shooting Star’ Amber Morrisey Studying the cellular changes that drive the initiation and progression of myeloid leukaemia $300,000 / 2015 to 2017 Exploiting natural killer cells in leukaemia treatment $120,000 / 2015 to 2017 PHD (CLINICAL) SCHOLARSHIPS Ms R. Austin QIMR Berghofer Medical Research Institute, QLD What factors drive immune response in acute myeloid leukaemia? $120,000 / 2015 to 2017 Dr P. Fedele Walter and Eliza Hall Institute of Medical Research, VIC Investigating the role of BLIMP1/PRDM1 and XBP1 as potential tumour suppressors in multiple myeloma $180,000 / 2015 to 2017 Dr M‐C Dubosq University of Sydney, Westmead Millennium Institute, NSW Supported by NSW Community Foundation, N & P Pinter Trust Generating genetically modified (CAR) T‐cells to treat blood cancers $180,000 / 2015‐2017 Mr A. Dutta University of Adelaide, School of Medicine Supported by ‘Shooting Star’ Louise Morrissey A genomic approach to understanding clonal evolution and disease transition in myeloma $120,000 / 2015 to 2017 For more information, visit www.leukaemia.org.au/research
VisiontoCure
Grant recipients were selected through a rigorous process. Independent expert peer
review committees rank the applications and make selection recommendations to
the Leukaemia Foundation’s Medical and Scientific Advisory Committee, an
independent panel of leading Australian blood cancer researchers, clinicians and
consumer representatives.
BRIDGESTONE CAREER ESTABLISHMENT GRANT Dr C. Keane University of Queensland Diamantina Institute and Princess Alexandra Hospital, QLD Supported by Bridgestone Australia Ltd Net tumoural immunity and its impact on outcome in lymphoma $150,000 / 2015 to 2017 CLINICAL TRIAL GRANT Professor S. Mulligan and Dr C. Tam Australasian Leukaemia and Lymphoma Group Australasian Phase II multicentre, randomised study of efficacy and safety for dose reduced fludarabine, cyclophosphamide and intravenous obinutuzumab compared to oral chlorambucil and intravenous obinutuzumab in previously untreated, co‐morbid elderly (≥65 yrs) patients with chronic lymphocytic leukaemia $300,000 / 2015 to 2017 DISCOVERY CENTRE GRANT Associate Professor P. Marlton Australasian Leukaemia and Lymphoma Group Funding for the ALLG Discovery Centre (formerly the ALLG Tissue Bank) $1,650,000 / 2015 to 2017 SUPPORTIVE CARE RESEARCH GRANT (To be announced) $50,000 / 2015 For more information, visit www.leukaemia.org.au/research